Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Oct. 13, 1999

DHA: a new treatment for CF on the horizon?

Oct. 13, 1999

Positive phase I/II reported for Nuvance at European meeting

Oct. 13, 1999

Sheffield and Elan establish licensing agreement to develop respiratory products

Oct. 12, 1999

Sch-55700 prevents a variety of eosinophilic responses in animal models

Oct. 7, 1999

PKC, cytokine inhibitors in development at AstraZeneca

Oct. 7, 1999

AstraZeneca receives FDA approval of Rhinocort Aqua Nasal Spray

Oct. 7, 1999

Nikken Chemicals prepares PDE4 inhibitors useful for allergic and inflammatory disorders

Oct. 6, 1999

Bayer's IL-4 antagonist for asthma enters clinical testing

Oct. 5, 1999

Zambon and Sheffield initiate MSI albuterol trial for treatment of pediatric asthma

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...